Mother-to-child transmission of HIV: experience at a referral hospital in Saudi Arabia

Jameela Edathodu, Magid M Halim, Muneera Bin Dahham, Abdulrahman A Alrajhi, Jameela Edathodu, Magid M Halim, Muneera Bin Dahham, Abdulrahman A Alrajhi

Abstract

Background and objectives: The rate of mother-to-child transmission of human immunodeficiency virus (HIV) type 1 has been reported to be high in Saudi Arabia. We report the rate of such transmission among a cohort of HIV-infected women enrolled in an HIV program at a tertiary care facility in Riyadh.

Methods: All HIV-infected women who became pregnant and delivered during their follow-up between January 1994 and June 2006 were included in this study. HIV viral load and CD4+ T-lymphocyte count near-term, the mode of delivery, and the HIV status of the newborn at 18 months were recorded. All women were counseled and managed according to the three-step PACTG 076 protocol.

Results: Of 68 HIV-infected women in the cohort, 31 had 40 pregnancies; one aborted at 13 weeks gestation. The mode of delivery was elective cesarean delivery in 28 pregnancies (70%) at 36 weeks gestation, and 11 (27.5%) had normal spontaneous vaginal delivery. The median CD4+ T-lymphocyte count near-term was 536 cells per cubic millimeter and the median viral load for 25 pregnancies was 1646 copies/mL, with only nine pregnancies (22.5%) having viral loads of more than 1000 copies/mL. Fourteen pregnancies (35%) had undetectable HIV prior to delivery. All patients were taking antiretroviral therapy during pregnancy and delivery. All 39 newborns tested negative for HIV infection at the age of 18 months; none of the newborns was breastfed.

Conclusions: Contrary to previous local experience, diagnosis, management, and antiretroviral therapy almost eliminated mother-to-child transmission of HIV-1 in our patient population.

References

    1. Centers for Disease Control (CDC) Unexplained immunodeficiency and opportunistic infections in infants. New York, New Jersey, California. MMWR Morb Mortal Wkly Rep. 1982;31:665–7.
    1. UNAIDS. 2008 report on the global HIV/AIDS epidemic. Joint United Nations Programme on HIV/AIDS [internet] 2008. [cited 2008 July]. Available from: .
    1. Brocklehurst P, Volmink J. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev. 2002:CD003510.
    1. Gray GE, McIntyre JA. HIV and pregnancy. BMJ. 2007;334:950–3.
    1. McIntyre J. Prevention of mother-to-child transmission of HIV: treatment options. Expert Rev Anti Infect Ther. 2005;3:971–80.
    1. Newell ML. Mechanisms and timing of mother-to-child transmission of HIV-1. AIDS. 1998;12:831–7.
    1. Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSherry GD, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant: Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1996;335:1621–9.
    1. Watts DH. Management of human immunodeficiency virus infection in pregnancy. N Engl J Med. 2002;346:1879–91.
    1. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment: Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994;331:1173–80.
    1. Madani TA, Al-Mazrou YY, Al-Jeffri MH, Al Huzaim NS. Epidemiology of the human immunodeficiency virus in Saudi Arabia: 18-year surveillance results and prevention from an Islamic perspective. BMC Infect Dis. 2004;4:25.
    1. Kordy F, Al-Hajjar S, Frayha HH, Al-Khlaif R, Al-Shahrani D, Akthar J. Human immunodeficiency virus infection in Saudi Arabian children: Transmission, clinical manifestations and outcome. Ann Saudi Med. 2006;26:92–9.
    1. al-Nozha MM, al-Frayh AR, al-Nasser M, Ramia S. Horizontal versus vertical transmission of human immunodeficiency virus type 1 (HIV-1): Experience from southwestern Saudi Arabia. Trop Geogr Med. 1995;47:293–5.
    1. Alrajhi AA, Halim MA, Al-Abdely HM. Presentation and reasons for HIV-1 testing in Saudi Arabia. Int J STD AIDS. 2006;17:806–9.
    1. Mofenson LM. Centers for Disease Control, U.S. Public Health Service Task Force. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. MMWR Recomm Rep. 2002;51:1–38. (RR-18)
    1. Boer K, Nellen JF, Patel D, Timmermans S, Tempelman C, Wibaut M, et al. The AmRo study: Pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery. BJOG. 2007;114:148–55.
    1. Maternal viral load and vertical transmission of HIV-1: An important factor but not the only one. The European Collaborative Study. AIDS. 1999;13:1377–85.
    1. Nduati R, John G, Mbori-Ngacha D, Richardson B, Overbaugh J, Mwatha A, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: A randomized clinical trial. JAMA. 2000;283:1167–74.

Source: PubMed

3
구독하다